title: Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
abstract: Metastatic progression of breast cancer involves phenotypic plasticity of the carcinoma cells moving between epithelial and mesenchymal behaviors. During metastatic seeding and dormancy, even highly aggressive carcinoma cells take on an E-cadherin-positive epithelial phenotype that is absent from the emergent, lethal metastatic outgrowths. These phenotypes are linked to the metastatic microenvironment, though the specific cells and induction signals are still to be deciphered. Recent evidence suggests that macrophages impact tumor progression, and may alter the balance between cancer cell EMT and MErT in the metastatic microenvironment.
  
  
  
  Here we explore the role of M1/M2 macrophages in epithelial-mesenchymal plasticity of breast cancer cells by coculturing epithelial and mesenchymal cells lines with macrophages.
  
  
  
  We found that after polarizing the THP-1 human monocyte cell line, the M1 and M2-types were stable and maintained when co-cultured with breast cancer cells. Surprisingly, M2 macrophages may conferred a growth advantage to the epithelial MCF-7 cells, with these cells being driven to a partial mesenchymal phenotypic as indicated by spindle morphology. Notably, E-cadherin protein expression is significantly decreased in MCF-7 cells co-cultured with M2 macrophages. M0 and M1 macrophages had no effect on the MCF-7 epithelial phenotype. However, the M1 macrophages impacted the highly aggressive mesenchymal-like MDA-MB-231 breast cancer cells to take on a quiescent, epithelial phenotype with re-expression of E-cadherin. The M2 macrophages if anything exacerbated the mesenchymal phenotype of the MDA-MB-231 cells.
  
  
  
  Our findings demonstrate M2 macrophages might impart outgrowth and M1 macrophages may contribute to dormancy behaviors in metastatic breast cancer cells. Thus EMT and MErT are regulated by selected macrophage phenotype in the liver metastatic microenvironment. These results indicate macrophage could be a potential therapeutic target for limiting death due to malignant metastases in breast cancer.
authors.affiliation: Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health System, Pittsburgh, PA, USA.|Current address: Institute of Materia Medica, Chinese Academy Medical of Sciences & Peking Union Medical College, 1 Xian Nong Tan Street, 100050, Beijing, China.
authors.forename: Min
authors.initials: M
authors.lastname: Yang
authors.affiliation: Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health System, Pittsburgh, PA, USA.
authors.forename: Bo
authors.initials: B
authors.lastname: Ma
authors.affiliation: Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health System, Pittsburgh, PA, USA.
authors.forename: Hanshuang
authors.initials: H
authors.lastname: Shao
authors.affiliation: Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health System, Pittsburgh, PA, USA.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Clark
authors.affiliation: Department of Pathology, University of Pittsburgh, and Pittsburgh VA Health System, Pittsburgh, PA, USA. wellsa@upmc.edu.
authors.forename: Alan
authors.initials: A
authors.lastname: Wells
mesh_terms: D015703:Antigens, CD; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D015820:Cadherins / Q000378:metabolism*; D002460:Cell Line; D002465:Cell Movement; D000066670:Cell Plasticity; D016764:Cell Polarity; D049109:Cell Proliferation; D018920:Coculture Techniques / Q000379:methods*; D018450:Disease Progression; D015536:Down-Regulation; D004847:Epithelial Cells / Q000166:cytology* / Q000378:metabolism; D058750:Epithelial-Mesenchymal Transition; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D061986:MCF-7 Cells; D008264:Macrophages / Q000166:cytology* / Q000378:metabolism
chemical_list: D015703:Antigens, CD; C513384:CDH1 protein, human; D015820:Cadherins
keywords: Epithelial to mesenchymal transition; Macrophage polarity; Mesenchymal to epithelial reverting transition; Metastatic microenvironment